MX2017009154A - Sintesis de un inhibidor de tirosina quinasa de bruton. - Google Patents
Sintesis de un inhibidor de tirosina quinasa de bruton.Info
- Publication number
- MX2017009154A MX2017009154A MX2017009154A MX2017009154A MX2017009154A MX 2017009154 A MX2017009154 A MX 2017009154A MX 2017009154 A MX2017009154 A MX 2017009154A MX 2017009154 A MX2017009154 A MX 2017009154A MX 2017009154 A MX2017009154 A MX 2017009154A
- Authority
- MX
- Mexico
- Prior art keywords
- bruton
- synthesis
- tyrosine kinase
- kinase inhibitor
- inhibitor
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
Abstract
En la presente memoria se describe la síntesis de inhibidor de tirosina quinasa de Bruton (Btk) de 1-((R)-3-(4-amino-3-(4-fenoxif enil)-1H-pirazol[3,4-d]pirimidin-1-il)piperidin-1-il)prop-2-en-1- ona.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201562103507P | 2015-01-14 | 2015-01-14 | |
PCT/US2016/013424 WO2016115356A1 (en) | 2015-01-14 | 2016-01-14 | Synthesis of a bruton's tyrosine kinase inhibitor |
Publications (2)
Publication Number | Publication Date |
---|---|
MX2017009154A true MX2017009154A (es) | 2017-10-12 |
MX366827B MX366827B (es) | 2019-07-25 |
Family
ID=56406389
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2017009154A MX366827B (es) | 2015-01-14 | 2016-01-14 | Sintesis de un inhibidor de tirosina quinasa de bruton. |
MX2019008815A MX2019008815A (es) | 2015-01-14 | 2017-07-12 | Sintesis de un inhibidor de tirosina quinasa de bruton. |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2019008815A MX2019008815A (es) | 2015-01-14 | 2017-07-12 | Sintesis de un inhibidor de tirosina quinasa de bruton. |
Country Status (16)
Country | Link |
---|---|
US (4) | US20180009814A1 (es) |
EP (1) | EP3245208A4 (es) |
JP (2) | JP2018502077A (es) |
KR (1) | KR20170102887A (es) |
CN (2) | CN107108640A (es) |
AU (2) | AU2016206693A1 (es) |
BR (1) | BR112017015206B1 (es) |
CA (2) | CA2971460C (es) |
HK (1) | HK1246293A1 (es) |
IL (3) | IL308276A (es) |
MA (1) | MA41350A (es) |
MX (2) | MX366827B (es) |
RU (1) | RU2017128308A (es) |
SG (2) | SG10201906517VA (es) |
WO (1) | WO2016115356A1 (es) |
ZA (1) | ZA201704338B (es) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2016127915A1 (zh) * | 2015-02-12 | 2016-08-18 | 上海度德医药科技有限公司 | 伊布替尼的制备方法 |
US11883404B2 (en) | 2016-03-04 | 2024-01-30 | Taiho Pharmaceuticals Co., Ltd. | Preparation and composition for treatment of malignant tumors |
CN109206426B (zh) * | 2017-07-06 | 2021-10-08 | 上海复星星泰医药科技有限公司 | 吡唑并嘧啶类化合物的制备方法 |
JP7166331B2 (ja) * | 2017-08-01 | 2022-11-07 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | 中間体化合物及び方法 |
CN107814804A (zh) * | 2017-10-27 | 2018-03-20 | 广州科锐特生物科技有限公司 | 依鲁替尼的制备方法 |
CA3094431C (en) | 2018-03-19 | 2023-06-27 | Taiho Pharmaceutical Co., Ltd. | Pharmaceutical composition including sodium alkyl sulfate |
CA3098497A1 (en) | 2018-05-03 | 2019-11-07 | Juno Therapeutics, Inc. | Combination therapy of a chimeric antigen receptor (car) t cell therapy and a kinase inhibitor |
JP6944496B2 (ja) * | 2018-10-22 | 2021-10-06 | ファイザー・インク | ピロロ[2,3−d]ピリミジントシル酸塩、その結晶形態、ならびにその製造方法および中間体 |
AU2018448845B2 (en) | 2018-11-09 | 2022-03-24 | Taiho Pharmaceutical Co., Ltd. | Method for producing dimethoxybenzene compound |
CN109988175A (zh) * | 2019-04-28 | 2019-07-09 | 梯尔希(南京)药物研发有限公司 | 一种依鲁替尼-d5的制备方法 |
US20220235058A1 (en) | 2019-05-21 | 2022-07-28 | Janssen Pharmaceutica Nv | Processes and intermediates for preparing a btk inhibitor |
CA3135240A1 (en) * | 2019-05-21 | 2020-11-26 | Philip James Pye | Processes and intermediates for preparing a btk inhibitor |
EP4281454A1 (en) | 2021-01-21 | 2023-11-29 | Synthon B.V. | Process for making ibrutinib |
CN114853662B (zh) * | 2021-02-05 | 2024-01-12 | 四川青木制药有限公司 | 手性肼基哌啶衍生物的制备方法 |
WO2023220655A1 (en) | 2022-05-11 | 2023-11-16 | Celgene Corporation | Methods to overcome drug resistance by re-sensitizing cancer cells to treatment with a prior therapy via treatment with a t cell therapy |
WO2023242384A1 (en) | 2022-06-17 | 2023-12-21 | Krka, D.D., Novo Mesto | Crystalline form of ibrutinib |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4550214A (en) * | 1981-01-05 | 1985-10-29 | Polaroid Corporation | Blocked vinyl biphenyl compounds |
US4874822A (en) * | 1988-04-07 | 1989-10-17 | Minnesota Mining And Manufacturing Company | Process for the acrylamidoacylation of alcohols |
CA2548374C (en) * | 2003-12-23 | 2014-05-27 | Astex Therapeutics Limited | Pyrazole derivatives as protein kinase modulators |
EP2081435B1 (en) * | 2006-09-22 | 2016-05-04 | Pharmacyclics LLC | Inhibitors of bruton's tyrosine kinase |
EP2560007A1 (en) * | 2007-03-28 | 2013-02-20 | Pharmacyclics, Inc. | Identification of bruton's tyrosine kinase inhibitors |
US7741330B1 (en) * | 2009-10-12 | 2010-06-22 | Pharmacyclics, Inc. | Pyrazolo-pyrimidine inhibitors of Bruton's tyrosine kinase |
MX2015001246A (es) * | 2012-07-30 | 2015-04-10 | Concert Pharmaceuticals Inc | Ibrutinib deuterado. |
CN103121999A (zh) * | 2012-08-29 | 2013-05-29 | 苏州迪飞医药科技有限公司 | 一种酪氨酸激酶抑制剂pci-32765的合成方法 |
US9156847B2 (en) * | 2013-03-15 | 2015-10-13 | Janssen Pharmaceutica Nv | Processes and intermediates for preparing a medicament |
US8957080B2 (en) * | 2013-04-09 | 2015-02-17 | Principia Biopharma Inc. | Tyrosine kinase inhibitors |
CN103626774B (zh) * | 2013-11-20 | 2015-11-04 | 苏州明锐医药科技有限公司 | 伊鲁替尼的制备方法 |
CN105471823B (zh) * | 2014-09-03 | 2018-10-26 | 阿里巴巴集团控股有限公司 | 一种敏感信息处理方法、装置、服务器及安全判定*** |
US10266535B2 (en) * | 2015-01-21 | 2019-04-23 | Hefei Institutes Of Physical Science, Chinese Academy Of Sciences | Inhibitor of FLT3 kinase and use thereof |
-
2016
- 2016-01-13 MA MA041350A patent/MA41350A/fr unknown
- 2016-01-14 KR KR1020177019206A patent/KR20170102887A/ko not_active Application Discontinuation
- 2016-01-14 BR BR112017015206-1A patent/BR112017015206B1/pt active IP Right Grant
- 2016-01-14 CA CA2971460A patent/CA2971460C/en active Active
- 2016-01-14 CN CN201680005456.4A patent/CN107108640A/zh active Pending
- 2016-01-14 JP JP2017532649A patent/JP2018502077A/ja active Pending
- 2016-01-14 CN CN202110485400.6A patent/CN113816962A/zh active Pending
- 2016-01-14 IL IL308276A patent/IL308276A/en unknown
- 2016-01-14 EP EP16737886.8A patent/EP3245208A4/en not_active Withdrawn
- 2016-01-14 MX MX2017009154A patent/MX366827B/es active IP Right Grant
- 2016-01-14 CA CA3210320A patent/CA3210320A1/en active Pending
- 2016-01-14 SG SG10201906517VA patent/SG10201906517VA/en unknown
- 2016-01-14 AU AU2016206693A patent/AU2016206693A1/en not_active Abandoned
- 2016-01-14 US US15/542,848 patent/US20180009814A1/en not_active Abandoned
- 2016-01-14 WO PCT/US2016/013424 patent/WO2016115356A1/en active Application Filing
- 2016-01-14 SG SG11201705678YA patent/SG11201705678YA/en unknown
- 2016-01-14 RU RU2017128308A patent/RU2017128308A/ru not_active Application Discontinuation
-
2017
- 2017-06-19 IL IL253020A patent/IL253020A0/en unknown
- 2017-06-26 ZA ZA2017/04338A patent/ZA201704338B/en unknown
- 2017-07-12 MX MX2019008815A patent/MX2019008815A/es unknown
-
2018
- 2018-05-07 HK HK18105861.5A patent/HK1246293A1/zh unknown
- 2018-12-18 US US16/224,425 patent/US20190367518A1/en not_active Abandoned
-
2019
- 2019-12-04 US US16/703,344 patent/US20200347064A1/en not_active Abandoned
-
2020
- 2020-05-17 IL IL274716A patent/IL274716A/en unknown
- 2020-09-11 AU AU2020230323A patent/AU2020230323A1/en not_active Abandoned
- 2020-10-09 JP JP2020171454A patent/JP2021035947A/ja active Pending
-
2021
- 2021-02-17 US US17/177,852 patent/US20220098200A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
BR112017015206B1 (pt) | 2023-04-11 |
CA2971460C (en) | 2023-10-10 |
US20200347064A1 (en) | 2020-11-05 |
SG11201705678YA (en) | 2017-08-30 |
EP3245208A4 (en) | 2018-10-17 |
WO2016115356A1 (en) | 2016-07-21 |
EP3245208A1 (en) | 2017-11-22 |
JP2018502077A (ja) | 2018-01-25 |
AU2016206693A1 (en) | 2017-07-13 |
US20220098200A1 (en) | 2022-03-31 |
IL253020A0 (en) | 2017-08-31 |
AU2020230323A1 (en) | 2020-10-01 |
CN113816962A (zh) | 2021-12-21 |
IL308276A (en) | 2024-01-01 |
RU2017128308A3 (es) | 2019-10-24 |
ZA201704338B (en) | 2023-10-25 |
BR112017015206A2 (pt) | 2018-06-19 |
MA41350A (fr) | 2017-11-21 |
IL274716A (en) | 2020-07-30 |
US20190367518A1 (en) | 2019-12-05 |
MX366827B (es) | 2019-07-25 |
SG10201906517VA (en) | 2019-08-27 |
RU2017128308A (ru) | 2019-02-14 |
JP2021035947A (ja) | 2021-03-04 |
CN107108640A (zh) | 2017-08-29 |
US20180009814A1 (en) | 2018-01-11 |
MX2019008815A (es) | 2019-09-26 |
CA2971460A1 (en) | 2016-07-21 |
KR20170102887A (ko) | 2017-09-12 |
CA3210320A1 (en) | 2016-07-21 |
HK1246293A1 (zh) | 2018-09-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2019008815A (es) | Sintesis de un inhibidor de tirosina quinasa de bruton. | |
BR112015021995A2 (pt) | combinações de inibidores de tirosina quinase de bruton e inibidores de cyp3a4 | |
DOP2022000096A (es) | Formas cristalinas de un inhibidor de tirosina quinasa de bruton | |
ZA201903932B (en) | Imidazopyrazine inhibitors of bruton's tyrosine kinase | |
EA201690746A1 (ru) | Лечение с применением ингибиторов тирозинкиназы брутона и иммунотерапии | |
MX2017001671A (es) | Formulaciones novedosas de un inhibidor de la tirosina cinasa de bruton. | |
MX2018008815A (es) | Inhibidores de tirosina quinasa de bruton. | |
MX2014000518A (es) | Inhibidores de la tirosina quinasa de bruton. | |
MX2017012411A (es) | Co-cristales de un inhibidor de tirosina cinasa de bruton. | |
EA201591656A1 (ru) | Комбинированная терапия с ибрутинибом | |
MX2019011116A (es) | Inhibidores de la tirosina quinasa de bruton. | |
PH12019501022A1 (en) | Pyrazolopyrimidine compounds and methods of use thereof | |
EP3273961A4 (en) | Solvated forms of a bruton's tyrosine kinase inhibitor | |
WO2016066726A3 (en) | Active acrylamides | |
EP3196199A4 (en) | Substituted n-(pyrrolidine-3-yl)-7h-pyrrolo[2,3-d]pyrimidine-4-amine as janus kinase inhibitor | |
EP3882241A4 (en) | INHIBITOR OF BRUTON TYROSINE KINASE | |
BR112018076622A2 (pt) | pirrolo[2,3-d]piridazin-4-onas e pirazolo[3,4-d]piridazin-4-onas substituídas como inibidores de proteína cinase | |
EP3412657A4 (en) | NEW IRREVERSIBLE INHIBITOR OF BRUTON TYROSINE KINASE | |
EP3966204A4 (en) | SUBSTITUTED 1-AMINO-1H-IMIDAZOLE-5-CARBOXAMIDE AS BRUTON TYROSINE KINASE INHIBITORS | |
EP4069689A4 (en) | SUBSTITUTED IMIDAZOLECARBOXAMIDE AS BRUTON TYROSINKINASE INHIBITORS | |
UY35800A (es) | Combinaciones de inhibidores de la tirosina quinasa de bruton e inmunoterapias |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant or registration |